Media Coverage Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALFORUM: AD Blood Tests are Here. Now, Let’s Grapple With How to Use Them Read More Joni Henderson 1/11/24 Joni Henderson 1/11/24 NPR: Blood tests can help diagnose Alzheimer’s - if they’re accurate enough. Not all are Read More Joni Henderson 11/8/23 Joni Henderson 11/8/23 Medical Device News: C2N’s Precivity blood biomarker test shows promise in Alzheimer’s screening Read More Joni Henderson 10/26/23 Joni Henderson 10/26/23 Medscape: Novel Tau Blood Biomarker Shows Promise Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 Proactive: BioVie says blinded data points to hopeful Alzheimer’s treatment potential Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 genomeweb: C2N Diagnostics MTBR-tau Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 Healio: Participation in digital cognitive test, biomarker assays linked to AD study enrollment Read More Joni Henderson 8/23/23 Joni Henderson 8/23/23 Fierce Biotech: C₂N Diagnostics launches revamped Alzheimer's blood test Read More Joni Henderson 8/18/23 Joni Henderson 8/18/23 Medical Device Network: C₂N launches new PrecivityAD® blood test Read More Joni Henderson 8/14/23 Joni Henderson 8/14/23 Alzheimer’s News Today: PrecivityAD® test for Alzheimer’s guided clinical decision-making Read More Joni Henderson 8/10/23 Joni Henderson 8/10/23 Being Patient: C₂N’s Alzheimer’s Blood Test in Phil’s Journal Read More Joni Henderson 7/21/23 Joni Henderson 7/21/23 Medpage Today: Alzheimer’s Blood Tests May Improve Primary Care Diagnoses Read More Joni Henderson 7/20/23 Joni Henderson 7/20/23 St. Louis Business Journal Award to C2N Read More Joni Henderson 7/7/23 Joni Henderson 7/7/23 STAT: We finally have new Alzheimer’s drugs. How do we decide who gets them? Read More Joni Henderson 4/19/23 Joni Henderson 4/19/23 Wall Street Journal: New Blood Tests Offer Possibly Early Detection of Cancer and Alzheimer’s Read More Joni Henderson 4/10/23 Joni Henderson 4/10/23 Fierce Biotech: C₂N’s amyloid- and tau detecting Alzheimer’s blood test outperforms other screening tools Read More Older Posts
Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More
Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More
Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More
Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More
Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALFORUM: AD Blood Tests are Here. Now, Let’s Grapple With How to Use Them Read More
Joni Henderson 1/11/24 Joni Henderson 1/11/24 NPR: Blood tests can help diagnose Alzheimer’s - if they’re accurate enough. Not all are Read More
Joni Henderson 11/8/23 Joni Henderson 11/8/23 Medical Device News: C2N’s Precivity blood biomarker test shows promise in Alzheimer’s screening Read More
Joni Henderson 10/26/23 Joni Henderson 10/26/23 Medscape: Novel Tau Blood Biomarker Shows Promise Read More
Joni Henderson 10/25/23 Joni Henderson 10/25/23 Proactive: BioVie says blinded data points to hopeful Alzheimer’s treatment potential Read More
Joni Henderson 10/25/23 Joni Henderson 10/25/23 Healio: Participation in digital cognitive test, biomarker assays linked to AD study enrollment Read More
Joni Henderson 8/23/23 Joni Henderson 8/23/23 Fierce Biotech: C₂N Diagnostics launches revamped Alzheimer's blood test Read More
Joni Henderson 8/18/23 Joni Henderson 8/18/23 Medical Device Network: C₂N launches new PrecivityAD® blood test Read More
Joni Henderson 8/14/23 Joni Henderson 8/14/23 Alzheimer’s News Today: PrecivityAD® test for Alzheimer’s guided clinical decision-making Read More
Joni Henderson 8/10/23 Joni Henderson 8/10/23 Being Patient: C₂N’s Alzheimer’s Blood Test in Phil’s Journal Read More
Joni Henderson 7/21/23 Joni Henderson 7/21/23 Medpage Today: Alzheimer’s Blood Tests May Improve Primary Care Diagnoses Read More
Joni Henderson 7/7/23 Joni Henderson 7/7/23 STAT: We finally have new Alzheimer’s drugs. How do we decide who gets them? Read More
Joni Henderson 4/19/23 Joni Henderson 4/19/23 Wall Street Journal: New Blood Tests Offer Possibly Early Detection of Cancer and Alzheimer’s Read More
Joni Henderson 4/10/23 Joni Henderson 4/10/23 Fierce Biotech: C₂N’s amyloid- and tau detecting Alzheimer’s blood test outperforms other screening tools Read More